Description: Precision medicine in biliary tract cancer - European Network for the Study of Cholangiocarcinoma
action (3606) cancer (3373) btc (1272) precision (887) cost (720) cholangiocarcinoma (4) 22125 (1) biliary tract (1) ens-cca (1)
Biliary tract cancers (BTC) include a heterogeneous group of aggressive tumours with an increasing incidence in Europe.
Heterogeneous group of aggressive tumours with an increasing incidence in Europe. Main challenges are represented by limited knowledge of risk factors, lack of biomarkers for diagnosis, unmet need for development of novel therapeutic strategies and harmonised access to novel drugs.
Creation of a life science ecosystem that supports interaction between basic scientists, clinicians, regulatory authorities, advocacy groups, SMEs and pharmaceutical industry partners